About Aurum Biosciences
Aurum Biosciences is a company based in Glasgow (United Kingdom) founded in 2015.. Aurum Biosciences has raised $6.3 million across 3 funding rounds from investors including Scottish Enterprise, Infinion BioPharma and InnoScot. The company has 6 employees as of March 31, 2022. Aurum Biosciences offers products and services including ABL-101 and ABL-101 Platform. Aurum Biosciences operates in a competitive market with competitors including Basking Biosciences, Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma and ZZ Biotech, among others.
- Headquarter Glasgow, United Kingdom
- Employees 6 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aurum Biosciences Limited
- Date of Incorporation 01 Nov, 2010
- Jurisdiction GLASGOW, SCOTLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.3 M (USD)
in 3 rounds
-
Latest Funding Round
$926.33 K (USD), Series A
Jan 31, 2024
-
Investors
Scottish Enterprise
& 7 more
-
Employee Count
6
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurum Biosciences
Aurum Biosciences offers a comprehensive portfolio of products and services, including ABL-101 and ABL-101 Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Injectable for oxygen delivery in stroke and spinal injury treatment
Platform for therapeutics and diagnostics in inflammation and oncology
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Aurum Biosciences
Aurum Biosciences has successfully raised a total of $6.3M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $926.33 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $926,326
-
First Round
First Round
(01 Sep 2015)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series A - Aurum Biosciences | Valuation | InnoScot | |
| Oct, 2020 | Amount | Seed - Aurum Biosciences | Valuation | Infinion BioPharma , Scottish Investment Bank |
|
| Sep, 2015 | Amount | Seed - Aurum Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aurum Biosciences
Aurum Biosciences has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Scottish Enterprise, Infinion BioPharma and InnoScot. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage Scottish companies are supported with investment and expertise.
|
Founded Year | Domain | Location | |
|
Supports healthcare innovation by assessing ideas, protecting IP, and facilitating commercial deals.
|
Founded Year | Domain | Location | |
|
Business development and leadership training programs are offered to companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aurum Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aurum Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aurum Biosciences Comparisons
Competitors of Aurum Biosciences
Aurum Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Basking Biosciences, Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma and ZZ Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for ischemic stroke treatment are developed.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies.
|
|
| domain | founded_year | HQ Location |
Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury.
|
|
| domain | founded_year | HQ Location |
Drugs for haemorrhagic stroke and intracranial haemorrhage are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered proteins for stroke and brain disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aurum Biosciences
Frequently Asked Questions about Aurum Biosciences
When was Aurum Biosciences founded?
Aurum Biosciences was founded in 2015.
Where is Aurum Biosciences located?
Aurum Biosciences is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Is Aurum Biosciences a funded company?
Aurum Biosciences is a funded company, having raised a total of $6.3M across 3 funding rounds to date. The company's 1st funding round was a Seed of $4.5M, raised on Sep 01, 2015.
How many employees does Aurum Biosciences have?
As of Mar 31, 2022, the latest employee count at Aurum Biosciences is 6.
What does Aurum Biosciences do?
Aurum Biosciences was founded in 2015 in Glasgow, United Kingdom, as a biopharmaceutical company. Novel perfluorocarbon-based oxygen carriers, known as Oxycyte, are combined with proprietary software and MRI imaging to form the Glasgow Oxygen Level Dependent (GOLD) technology. This is advanced through preclinical development and clinical studies for acute ischaemic stroke, serving as both a diagnostic tool and therapeutic option, with potential follow-on indications.
Who are the top competitors of Aurum Biosciences?
Aurum Biosciences's top competitors include Acticor Biotech, Remedy Pharmaceuticals and Basking Biosciences.
What products or services does Aurum Biosciences offer?
Aurum Biosciences offers ABL-101 and ABL-101 Platform.
Who are Aurum Biosciences's investors?
Aurum Biosciences has 8 investors. Key investors include Scottish Enterprise, Infinion BioPharma, InnoScot, TRICAPITAL Angels, and Celestine Santosh.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.